NYSE:ZBH
Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings, Inc.'s revenue grew 7.2% in fiscal 2025 to $8.2B while operating margin fell to 13.3%. Free cash flow was $1.5B, 17.9% of revenue, and the diluted share count fell 2.6%.Summary generated from Zimmer Biomet Holdings, Inc.'s SEC filings. Latest annual report filed Feb 20, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$8.2B
Revenue growth+7.2%
Revenue, 5-yr CAGR+6.1%
Gross margin69.7%
Operating margin13.3%
Net margin8.6%
ROIC4.9%
Return on equity5.6%
Debt / equity0.59
Free cash flow$1.5B
FCF margin17.9%
Share count change−2.6%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 6,827 | 6,940 | 7,394 | 7,679 | 8,232 |
| Operating income | 860 | 696 | 1,278 | 1,286 | 1,098 |
| Net income | 402 | 231 | 1,024 | 904 | 705 |
| Free cash flow | 1,356 | 1,168 | 1,291 | 1,296 | 1,473 |
Recent filings
- 4Insider transaction report
Oct 5, 2026 - 4Insider transaction report
Oct 2, 2026 - 8-KDirector or officer change
Sep 8, 2026 - 8-KOther events
Aug 5, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 5, 2026 - 8-KResults of operations and financial condition
Aug 5, 2026 - 8-KEntry into a material agreement
Jun 29, 2026 - 8-KResults of a shareholder vote
May 27, 2026